Market revenue in 2022 | USD 184.3 million |
Market revenue in 2030 | USD 319.7 million |
Growth rate | 7.1% (CAGR from 2022 to 2030) |
Largest segment | Lead identification & candidate optimization |
Fastest growing segment | Other Associated Workflow |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery outsourcing market will help companies and investors design strategic landscapes.
Lead identification & candidate optimization was the largest segment with a revenue share of 32.66% in 2022. Horizon Databook has segmented the Germany drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2018 to 2030.
German Research Foundation (DFG) is a research funding organization that selects projects from researchers and research institutions and finances them. In 2011, German Federal Ministry for Education and Research established the German Center for Infection Research with the objective of developing new drug candidates in collaboration with many research institutions and organizations.
This approach may bridge the gap between discovery of new treatment approaches, their preclinical development, and clinical testing as well as encourage the participation of larger pharmaceutical firms.
Moreover, international collaborations between major enterprises for the development of small molecule-based novel drugs are anticipated to spur the growth of German drug discovery outsourcing market in near future.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany drug discovery outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Germany drug discovery outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account